ASX Announcement

Final Patient Dosed in Mesoblast P3 Heart Failure Trial

Published: 19/02/19, 09:27am (AEST)2 pages
Mesoblast Limited
MSB:ASXHealthcare

Recent MSB Announcements

Price Sensitive only